1 April 1997

Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms

Abstract

Although CD8+ lymphocytes in human immunodeficiency virus type 1 (HIV-1)-infected individuals have been demonstrated to suppress viral replication, the mechanisms of inhibition have not been defined precisely. A large body of evidence indicates that these cells act via soluble inhibitory factors, but the potential role of HLA class I-restricted cytolysis has remained controversial. Here we demonstrate that HIV-1-specific cytotoxic T lymphocytes (CTL) mediate antiviral suppression by both cytolytic and noncytolytic mechanisms. The predominant mechanism requires direct contact of CTL with the infected cells, is HLA class I restricted, and can achieve complete elimination of detectable virus in infected cell cultures. Inhibition occurs even at high multiplicities of infection or at ratios of CTL to CD4 cells as low as 1:1,000. The other mechanism is mediated by soluble inhibitory factors which are triggered in an antigen-specific and HLA-restricted fashion but then act without HLA restriction. These include MIP-1alpha, MIP-1beta, and RANTES, as well as a distinct factor(s) capable of inhibiting HIV-1 strains insensitive to these chemokines. These data indicate that HIV-1-specific CTL are potent mediators of HIV-1 suppression at cell ratios existing in vivo and demonstrate an antigen-specific trigger for CD8+ cell-derived soluble inhibitory factors. These results suggest that CTL play an important role in the observed antiviral activity of CD8+ cells from infected individuals.

Formats available

You can view the full content in the following formats:

Information & Contributors

Information

Published In

cover image Journal of Virology
Journal of Virology
Volume 71Number 4April 1997
Pages: 3120 - 3128
PubMed: 9060675

History

Published online: 1 April 1997

Permissions

Request permissions for this article.

Contributors

Authors

O O Yang
AIDS Research Center, Massachusetts General Hospital and Harvard Medical School, Charlestown 02129, USA.
S A Kalams
AIDS Research Center, Massachusetts General Hospital and Harvard Medical School, Charlestown 02129, USA.
A Trocha
AIDS Research Center, Massachusetts General Hospital and Harvard Medical School, Charlestown 02129, USA.
H Cao
AIDS Research Center, Massachusetts General Hospital and Harvard Medical School, Charlestown 02129, USA.
A Luster
AIDS Research Center, Massachusetts General Hospital and Harvard Medical School, Charlestown 02129, USA.
R P Johnson
AIDS Research Center, Massachusetts General Hospital and Harvard Medical School, Charlestown 02129, USA.
B D Walker
AIDS Research Center, Massachusetts General Hospital and Harvard Medical School, Charlestown 02129, USA.

Metrics & Citations

Metrics

Note:

  • For recently published articles, the TOTAL download count will appear as zero until a new month starts.
  • There is a 3- to 4-day delay in article usage, so article usage will not appear immediately after publication.
  • Citation counts come from the Crossref Cited by service.

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.

View Options

Figures and Media

Figures

Media

Tables

Share

Share

Share the article link

Share with email

Email a colleague

Share on social media

American Society for Microbiology ("ASM") is committed to maintaining your confidence and trust with respect to the information we collect from you on websites owned and operated by ASM ("ASM Web Sites") and other sources. This Privacy Policy sets forth the information we collect about you, how we use this information and the choices you have about how we use such information.
FIND OUT MORE about the privacy policy